Ludovic Landemarre

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Pharmaceutics

Diagnostics (Basel, Switzerland)

Chemical communications (Cambridge, England)

GLYcoDiag

CNRS Campus Orléans (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GLYcoDiag Jul 25 2005

France

CEO - CSO :: R and D

Education History

CNRS Campus Orléans - May 06 1996

France

PHD :: molecular biophysics center

Publications

Mateja Seničar, Benoît Roubinet, Pierre Lafite, Laurent Legentil, Vincent Ferrieres, Ludovic Landemarre, Richard Daniellou
Gal f -Specific Neolectins: Towards Promising Diagnostic Tools. International journal of molecular sciences 25 (9) (2024)
Mateja Seničar, Benoît Roubinet, Pierre Lafite, Laurent Legentil, Vincent Ferrieres, Ludovic Landemarre, Richard Daniellou
Gal f -Specific Neolectins: Towards Promising Diagnostic Tools. International journal of molecular sciences 25 (9) (2024)
Mateja Seničar, Benoît Roubinet, Pierre Lafite, Laurent Legentil, Vincent Ferrieres, Ludovic Landemarre, Richard Daniellou
Gal f -Specific Neolectins: Towards Promising Diagnostic Tools. International journal of molecular sciences 25 (9) (2024)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Tao Wang, Ravikumar Jimmidi, Benoit Roubinet, Ludovic Landemarre, Stéphane P Vincent
Glycofullerene-AuNPs as multivalent ligands of DC-SIGN and bacterial lectin FimH: tuning nanoparticle size and ligand density. Nanoscale (2023)
Camille Niveau, Eleonora Sosa Cuevas, Benoît Roubinet, Mylène Pezet, Michel Thépaut, Stéphane Mouret, Julie Charles, Franck Fieschi, Ludovic Landemarre, Laurence Chaperot, Philippe Saas, Caroline Aspord
Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding. Immunology (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Mateja Seničar, Benoît Roubinet, Richard Daniellou, Thierry Prazuck, Ludovic Landemarre
Lectin Analysis of SARS-CoV-2-Positive Nasopharyngeal Samples Using GLYcoPROFILE ® Technology Platform. Diagnostics (Basel, Switzerland) 12 (11) (2022)
Mateja Seničar, Pierre Lafite, Svetlana V Eliseeva, Stéphane Petoud, Ludovic Landemarre, Richard Daniellou
Galactofuranose-Related Enzymes: Challenges and Hopes. International journal of molecular sciences 21 (10) (2020)
Madeleine Cauwel, Adeline Sivignon, Clarisse Bridot, Medy C Nongbe, David Deniaud, Benoit Roubinet, Ludovic Landemarre, François-Xavier Felpin, Julie Bouckaert, Nicolas Barnich, Sébastien G Gouin
Heptylmannose-functionalized cellulose for the binding and specific detection of pathogenic E. coli. Chemical communications (Cambridge, England) 55 (68) (2019)

Ludovic Landemarre.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ludovic Landemarre